Dysfunction of the mitotic:meiotic switch as a potential cause of neoplastic conversion of primordial germ cells.
Germ cell tumours (GCT) are thought to arise as the result of a defect in early development, probably shortly after arrival of the migrating primordial germ cells (PGC) in the genital ridge when, if in a male genital ridge, the germ cells arrest in mitosis, but in a female genital ridge they enter meiosis. We suggest that dysfunction of the mitotic:meiotic switch, with cells aberrantly co-expressing functions pertinent to both states, might provide the genetic instability that could initiate tumour development. If this hypothesis is correct, GCT could arise because of disruption in the function of any one of a number of different genes involved in controlling mitosis and meiosis, rather than being dependent upon a single prominent susceptibility gene. The Notch signalling system is one candidate system for controlling the switch and we have identified expression of Notch2 and Notch4 in seminomas and carcinoma in situ. Thus those two members of the Notch family are candidates for proto-oncogenes that could play a role in GCT development. We have also identified a human homologue of the synaptonemal complex protein, SCP3, and have found its apparently aberrant expression in some established EC cell lines. One possibility is that abnormal regulation of such proteins involved in the synaptonemal complex could also lead to genetic instability in PGC and so also initiate tumour development.
Adamah
D J B
DJ
Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield, UK.
Gokhale
P J
PJ
Eastwood
D J
DJ
Rajpert De-Meyts
E
E
Goepel
J
J
Walsh
J R
JR
Moore
H D
HD
Andrews
P W
PW
D018797:Cell Cycle Proteins; D002460:Cell Line; D004268:DNA-Binding Proteins; D006801:Humans; D008297:Male; D008540:Meiosis; D008938:Mitosis; D009373:Neoplasms, Germ Cell and Embryonal / Q000235:genetics / Q000378:metabolism*; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000378:metabolism*; D051883:Receptor, Notch2 / Q000235:genetics / Q000378:metabolism*; D000074562:Receptor, Notch4; D051880:Receptors, Notch / Q000235:genetics / Q000378:metabolism*; D018239:Seminoma / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction; D013234:Stem Cells / Q000166:cytology*
D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; C497764:NOTCH2 protein, human; C106075:NOTCH4 protein, human; D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins; D051883:Receptor, Notch2; D000074562:Receptor, Notch4; D051880:Receptors, Notch; C490060:SYCP3 protein, human